Modulation of atherogenesis by dietary gamma-linolenic acid

Y. Y. Fan, K. S. Ramos, R. S. Chapkin

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Data from our in vitro studies indicate that macrophages isolated from mice fed GLA-enriched diets inhibit vascular SMC proliferation via a PGE1-cAMP dependent mechanism. Since SMC proliferation is one of the main events implicated in the pathogenesis of atherosclerosis (Ross, 1993), this anti-proliferative effect observed by dietary GLA is noteworthy. In vivo studies have established that dietary. GLA is capable of retarding the atherosclerotic lesion formation in ApoE knock out mice, an animal model that develops atherosclerosis similar to humans (Reddick, 1994). We propose that dietary GLA has the potential to inhibit SMC proliferation leading to retardation of atherosclerotic lesion formation, and therefore favorable modulation of the atherogenic process.

Original languageEnglish (US)
Pages (from-to)485-491
Number of pages7
JournalAdvances in experimental medicine and biology
StatePublished - 2000

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology


Dive into the research topics of 'Modulation of atherogenesis by dietary gamma-linolenic acid'. Together they form a unique fingerprint.

Cite this